

Rapid Saliva Testing Devices Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Rapid Saliva Testing Devices market is experiencing significant growth, driven by increasing demand for non-invasive diagnostics and efficient screening methods. The market size is projected to reach approximately $1.5 billion by 2028, reflecting a compound annual growth rate (CAGR) of 15% as healthcare systems prioritize rapid testing solutions. Request Sample Report
◍ Abbott Laboratories
◍ Guangzhou Wondfo Biotech
◍ OraSure Technologies
◍ Quest Diagnostics
◍ Neogen Corporation
◍ Oranoxis Inc
◍ Premier Biotech
◍ Securetec Detektions-Systeme
◍ UCP Biosciences (Chinese Peptide Co)
◍ Screen Italia
◍ AccuBioTech
◍ MEDACX Ltd
◍ Oasis Diagnostics
The Rapid Saliva Testing Devices Market features key players like Abbott Laboratories, Guangzhou Wondfo Biotech, and OraSure Technologies. These companies enhance market growth through innovation, expanding product offerings, and strategic partnerships. Sales revenue figures include: Abbott: $42 billion; Quest Diagnostics: $7.5 billion; Neogen: $437 million, driving sector advancement. Request Sample Report
◍ Workplace Testing
◍ Criminal Justice Testing
◍ 5-Panel Saliva Test Kits
◍ 6-Panel Saliva Test Kits
◍ Disease Testing Request Sample Report
◍ 10-Panel Saliva Test Kits
◍ 12-Panel Saliva Test Kits
◍ Others
Request Sample Report
$ X Billion USD